Coloplast A/S (CLPBY)
7.348
-0.13
(-1.77%)
USD |
OTCM |
Nov 18, 16:00
Coloplast Price to Book Value : 7.625 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 7.625 |
| November 17, 2026 | 7.763 |
| November 16, 2026 | 7.742 |
| November 13, 2026 | 7.773 |
| November 12, 2026 | 7.555 |
| November 11, 2026 | 7.638 |
| November 10, 2026 | 7.597 |
| November 09, 2026 | 7.825 |
| November 06, 2026 | 7.877 |
| November 05, 2026 | 8.136 |
| November 04, 2026 | 8.230 |
| November 03, 2026 | 7.659 |
| November 02, 2026 | 7.005 |
| October 30, 2026 | 7.514 |
| October 29, 2026 | 7.472 |
| October 28, 2026 | 7.462 |
| October 27, 2026 | 7.441 |
| October 26, 2026 | 7.524 |
| October 23, 2026 | 7.607 |
| October 22, 2026 | 7.514 |
| October 21, 2026 | 7.368 |
| October 20, 2026 | 7.462 |
| October 19, 2026 | 7.325 |
| October 16, 2026 | 7.348 |
| October 15, 2026 | 7.306 |
| Date | Value |
|---|---|
| October 14, 2026 | 7.140 |
| October 13, 2026 | 7.192 |
| October 12, 2026 | 6.984 |
| October 09, 2026 | 6.850 |
| October 08, 2026 | 6.704 |
| October 07, 2026 | 6.652 |
| October 06, 2026 | 6.590 |
| October 05, 2026 | 6.466 |
| October 02, 2026 | 6.414 |
| October 01, 2026 | 6.497 |
| September 30, 2026 | 6.559 |
| September 29, 2026 | 7.066 |
| September 28, 2026 | 7.110 |
| September 25, 2026 | 7.121 |
| September 24, 2026 | 7.099 |
| September 23, 2026 | 7.077 |
| September 22, 2026 | 7.121 |
| September 21, 2026 | 7.132 |
| September 18, 2026 | 7.110 |
| September 17, 2026 | 7.176 |
| September 16, 2026 | 7.110 |
| September 15, 2026 | 7.187 |
| September 14, 2026 | 7.220 |
| September 11, 2026 | 7.242 |
| September 10, 2026 | 7.441 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ambu A/S | 3.650 |
| Abbott Laboratories | 3.546 |
| AngioDynamics, Inc. | 2.929 |
| Alphatec Holdings, Inc. | -- |
| AtriCure, Inc. | 5.294 |
Price to Book Value Related Metrics
| PE Ratio | 34.82 |
| PS Ratio | 3.680 |
| Price to Free Cash Flow | 16.53 |
| Price | 7.348 |
| Earnings Yield | 2.87% |
| Market Cap | 15.24B |
| Operating PE Ratio | 14.46 |
| Normalized PE Ratio | 20.34 |